Journal articleContemp Clin Trials · January 2018
INTRODUCTION: Acute decompensated heart failure (ADHF) is the leading cause of hospitalization in older adults. Rehabilitation Therapy in Older Acute Heart Failure Patients (REHAB-HF) trial is a multi-site clinical trial to determine if physical rehabilita ...
Full textLink to itemCite
Journal articleAnn Thorac Surg · July 2016
BACKGROUND: Robotic technology is one of the most recent technological changes in coronary artery bypass graft (CABG) operations. The current analysis was conducted to identify trends in the use and outcomes of robotic-assisted CABG (RA-CABG). METHODS: A r ...
Full textLink to itemCite
Journal articleJ Card Fail · June 2016
BACKGROUND: Younger age as an independent predictor of death or all-cause rehospitalization at 30 days post-randomization for hospitalized heart failure (HF) patients has not been well described. METHODS AND RESULTS: ASCEND-HF enrolled 7141 hospitalized ac ...
Full textLink to itemCite
Journal articleHeart Fail Clin · July 2015
The need for HF management is predicted to increase as the HF population ages. Balancing HF and the multiple cardiac comorbidities remains difficult for any single provider, but becomes Fig. 6. Five-year rates of death or urgent heart transplantation by de ...
Full textLink to itemCite
Journal articleAm Heart J · April 2015
BACKGROUND: Few guidelines exist regarding authorship on manuscripts resulting from large multicenter trials. The HF-ACTION investigators devised a system to address assignment of authorship on trial publications and tested the outcomes in the course of co ...
Full textLink to itemCite
Journal articleAm Heart J · October 2014
BACKGROUND: Discontinuations and/or interruptions in aspirin therapy for secondary cardioprotection due to upper gastrointestinal (UGI) complications or symptoms have been shown to increase the risk for subsequent cardiovascular events. PA32540 is a coordi ...
Full textLink to itemCite
Journal articleAm J Cardiol · January 1, 2013
The aim of the present study was to evaluate whether diagnostic data collected after a heart failure (HF) hospitalization can identify patients with HF at risk of early readmission. The diagnostic data from cardiac resynchronization therapy defibrillator ( ...
Full textLink to itemCite
Journal articleJ Card Fail · June 2012
BACKGROUND: Guidelines recommend hospice care as a treatment option for end-stage heart failure (HF) patients. Little is known regarding utilization of hospice care in a contemporary cohort of patients hospitalized with HF and how this may vary by estimate ...
Full textLink to itemCite
Journal articleJ Card Fail · February 2012
BACKGROUND: Despite the high number of admissions for acute decompensated heart failure (ADHF), there are no specific criteria for discharge readiness. A number of patients have implantable devices that might provide data to assist in determining readiness ...
Full textLink to itemCite
Journal articleAm Heart J · December 2011
BACKGROUND: This post hoc analysis of the HF-ACTION cohort explores the primary and secondary results of the HF-ACTION study by etiology and severity of illness. METHODS: HF-ACTION randomized stable outpatients with reduced left ventricular (LV) function a ...
Full textLink to itemCite
Journal articleJ Card Fail · August 2011
BACKGROUND: This study was undertaken to identify predictors of hospital length of stay (LOS) for heart failure (HF) patients using clinical variables available at the time of admission and hospital characteristics. METHODS AND RESULTS: A cohort of 70,094 ...
Full textLink to itemCite
Journal articleProg Cardiovasc Dis · 2011
Over the past decade, emerging clinical trial data supported the usefulness of implanted therapeutic cardiac devices (pacemakers and defibrillators) for the treatment of heart failure (HF). Interest has now developed in evaluating the potential of device d ...
Full textLink to itemCite
Journal articleJ Am Coll Cardiol · April 27, 2010
OBJECTIVES: We sought to determine the utility of combined heart failure (HF) device diagnostic information to predict clinical deterioration of HF in patients with systolic left ventricular dysfunction. BACKGROUND: Some implantable devices continuously mo ...
Full textLink to itemCite
Journal articleCirc Cardiovasc Qual Outcomes · January 2010
BACKGROUND: Inpatient care is the primary driver of costs for patients with heart failure. It is unclear whether recent advances in heart failure care have reduced the costs to Medicare for the care of inpatients with heart failure. METHODS AND RESULTS: In ...
Full textLink to itemCite
Journal articleClin Pharmacol Ther · July 2009
The cardiovascular safety of new drugs is an overarching concern for all stakeholders: the pharmaceutical industry and the US Food and Drug Administration (FDA) prior to approval and doctors and patients during postrelease drug use. Of the many cardiac saf ...
Full textLink to itemCite
Journal articleAm Heart J · November 2008
BACKGROUND: Heart failure (HF) is a common medical problem with significant morbidity and mortality. Recently, device-based therapy, cardiac resynchronization therapy (CRT), implantable cardioverter-defibrillators (ICDs), and combined CRT and ICD have beco ...
Full textLink to itemCite
Journal articleAm Heart J · February 2007
BACKGROUND: Although there are limited clinical data to support the use of exercise training as a means to reduce mortality and morbidity in patients with heart failure, current guidelines state that exercise is beneficial. TRIAL DESIGN: The objective of t ...
Full textLink to itemCite
Journal articleAm J Cardiol · January 15, 2007
Although heart failure disease management (HFDM) programs improve patient outcomes, the implementation of these programs has been limited because of financial barriers. We undertook the present study to understand the economic incentives and disincentives ...
Full textLink to itemCite
Journal articleAm Heart J · April 2005
BACKGROUND: The medical community has turned to disease management (DM) to bridge the gap between proven therapies and clinical practice for patients with heart failure (HF). The aim of this study was to assess the effectiveness of DM programs in reducing ...
Full textLink to itemCite